Iconic and utterly baffling in equal measure, there's something nostalgic about a Punch and Judy show. But did you know there ...

Announced Vertex Agreement to Acquire Crinetics for Total Equity Value of Approximately $10.0 Billion, or Approximately $8.8B Net of ...

The Food and Drug Administration (FDA) has accepted the resubmitted New Drug Application (NDA) for CAM2029 (octreotide) extended-release injection for the treatment of patients with acromegaly. The ...

Even after a successful surgery to remove the tumor responsible for excess growth hormone production, living with acromegaly can demand a lot: follow-up lab tests, medications to further reduce ...

The boards of directors at both companies have unanimously approved the deal, which is expected to close in the third calendar quarter of this year. Vertex is buying a company that recently earned its ...

Perhaps the biggest asset Crinetics brings is a drug called PALSONIFY -- the first and only once-daily oral therapy approved for adults with acromegaly. It won U.S. approval in September 2025 and was ...

Vertex Pharmaceuticals will buy Crinetics Pharmaceuticals for a total equity value of about $10 billion, the companies said on Monday, adding treatments for rare hormonal diseases to its portfolio.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...

Add Yahoo as a preferred source to see more of our stories on Google. For most people with acromegaly, symptoms improve once the tumor responsible for excess production of growth hormone is surgically ...

Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex's portfolio - PALSONIFY, Crinetics' recently launched, first ...

PALSONIFY™ (Paltusotine) Net Product Revenue of $10.3 Million for First-Quarter 2026, with 232 Enrollment Forms in the First Quarter SAN DIEGO, May 07, 2026 (GLOBE NEWSWIRE)-- Crinetics ...

An acromegaly diagnosis can feel overwhelming, and because it’s a rare disorder, it may seem like you’re alone in your symptoms and treatment journey. Your doctor may focus on your hormone levels, but ...